Advanced Health Intelligence (AHI) Stock Price, News & Analysis

Company Overview

Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual's health. The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, wellness, and government sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$20.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AHI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Advanced Health Intelligence own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Health Intelligence investors own include Atalaya Mining (AYM), Atalaya Mining (ATYM), Activision Blizzard (ATVI), Arrival (ARVL), Arqit Quantum (ARQQ), American Lithium Minerals (AMLM) and Altimmune (ALT).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: Computer Software
• Current Symbol: ASX:AHI
• CIK: N/A
• Web: www.advancedhumanimaging.com
• Phone: 61 8 9324 2099
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$16.66 million
• Net Margins: -293.71%
• Pretax Margin: N/A
• Return on Equity: 1,150.79%
• Return on Assets: -95.39%

Debt

• Debt-to-Equity Ratio: 122.04
• Current Ratio: 0.06
• Quick Ratio: 2.96

Sales & Book Value

• Annual Sales: A$271.01 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.01 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 217,700,000
• Free Float: N/A
• Market Cap: A$20.52 million
• Optionable: Not Optionable
• Beta: 1.46